This Morning star reveals HUGE change to the show amid ITV cuts
A THIS Morning star has revealed a pretty seismic change to the show's rules amid the ITV cuts and subsequent bloodbath.
Sweeping changes were announced earlier this month to ITV Daytime shows that will impact the likes of This Morning, Loose Women and Lorraine.
6
6
6
6
6
More than 220 jobs will be lost as part of the shake-up — meaning almost half of the 450 employed on the four flagship shows GMB, Lorraine, This Morning and Loose Women will be let go.
But amid the changes, This Morning have introduced a new rule.
The show has long had an unwritten rule in place that meant presenters could not wear a specific item of clothing.
All of the presenters - past and present - are known for being dressed smartly.
Rochelle Humes, who is now a staple of the This Morning rotation, revealed the new rule.
Ahead of an episode earlier this week, Rochelle took to TikTok to tell her fans about the rule change.
The 35-year-old former star of The Saturdays said: "There's a new rule, we didn't used to be allowed to wear jeans, did we?
"But we can wear jeans now.
"This is amazing news for me."
Reacting to her video on the social media platform, fans were quick to swoon over the outfit she had picked out for the show.
This Morning viewers can't believe Dermot O'Leary's 'real age' as he and Alison Hammond celebrate his birthday on air
"Smart yet casual yet fun & relaxed," said one.
"Obsessed with this outfit," penned a second.
Rochelle then appeared live on the show wearing a pair of light-wash River Island denim jeans.
This isn't the only way the show has started to become more relatable.
ITV's daytime TV schedule changes in full
Good Morning Britain will be extended by 30 minutes to run from 6am to 9.30am daily.
Lorraine will run from 9.30am-10am, on a seasonal basis for 30 weeks of the year.
During the weeks Lorraine is not on air, Good Morning Britain will run from 6am to 10am.
This Morning will remain in its 10am-12.30pm slot on weekdays throughout the year.
Loose Women will be in the 12.30-1.30pm slot, again on a seasonal basis for 30 weeks of the year.
The changes will take effect from January 2026.
Cat Deeley, who is one of the show's new anchors, was recently asked to embrace her Brummie accent.
The star's Birmingham accent was softened during her years on American TV, but now she has been asked to lean back into it as to appeal to the UK audience.
An ITV insider previously told MailOnline: "This Morning want presenters their audiences can relate to and there were worries Cat was too perfect and preened."
This comes amid ITV's shocking shakeup that will see hundreds of people lose their jobs at the channel.
Good Morning Britain will be extended by 30 minutes to run from 6am to 9.30am daily.
Lorraine will run from 9.30am-10am, on a seasonal basis for 30 weeks of the year.
During the weeks Lorraine is not on air, Good Morning Britain will run from 6am to 10am.
This Morning will remain in its 10am-12.30pm slot on weekdays throughout the year.
Loose Women will be in the 12.30-1.30pm slot, again on a seasonal basis for 30 weeks of the year.
The changes will take effect from January 2026.
Visit our This Morning page for the latest updates
6
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
29 minutes ago
- BBC News
New investment in Argyle has fallen through
Plymouth Argyle chairman Simon Hallett says proposed new investment in the club has fallen who first invested in the Pilgrims in 2016 and became majority shareholder two years later, had agreed in principle to sell a stake in the club to new in a statement following confirmation that head coach Miron Muslic has joined German side Schalke, Hallett says the deal is comes a month after Argyle were relegated from the Championship, having finished 23rd in the second tier."We have been in talks with a prospective new investor in our club for over a year - those talks led to an application for approval of that investment being lodged with the EFL in February," he said."Unfortunately, negotiations have taken too long and the key information that both we and the EFL required to complete the deal has not been forthcoming. I no longer believe that news of the new investor is imminent." Hallett says he and the club's existing shareholders - Argyle Green and the Holliday family - will match the level of funding they had planned with the new investor for this season, a level he says is twice the budget the club had when they won League One in Hallett's ownership, Argyle have redeveloped the Mayflower Grandstand and are helping to fund new academy facilities at what was the also bought land adjacent to Home Park to improve the first team's training facilities."I completely understand that this will be very frustrating for fans, as it is extremely frustrating for me and the rest of the Argyle board," he added."I have said constantly that my resources can enable us to be a sustainable Championship club, but that if we wish to aspire beyond that we would need new investment. I can provide some of that new investment, with the Holliday family's and Argyle Green's help, but not all."While progress towards a transaction in its current form looks to have stalled, we will continue to explore alternative routes, including being open to revised terms with other investment groups."It is important we get the right investor, not the quickest investor, and this may take some time. We are committed to this, but in the meantime, current shareholders can (and will) support the club through its next stage of development."
Daily Mail
36 minutes ago
- Daily Mail
Thousands of women with incurable breast cancer thrown a lifeline - doctors say hope is now possible
A first-of-its-kind daily pill that slows the spread of aggressive breast cancer is set to revolutionise the treatment of thousands, experts say. A trial has found that the drug, vepdegestrant, is twice as effective as existing treatments at extending the lives of patients with incurable breast cancer—buying them precious time with loved ones. Experts say that vepdegestrant also has far fewer side effects than medicines used on the NHS, and can be taken at home. One in seven women in the UK are diagnosed with breast cancer in their lifetime—around 56,000 a year—making it the most common cancer in the UK. While nine out ten patients survive, the disease still claims the lives of more than 11,000 annually. Around two-thirds of breast cancer patients in the UK have a form of the disease called ER positive HER-2 negative breast cancer. Of these, up to half with an advanced form can develop a genetic mutation which makes their cancer resistant to treatment. Patients who get this mutation—called ESR1—typically have less than two years to live. Currently, these patients receive a once-a-month injection called fulvestrant, which stops cancer cells from feeding off oestrogen, the female sex hormone that research shows helps tumours to grow. However, fulvestrant, which has to be adminstered by a healthcare professional, has a number of uncomfortable side effects including hot flushes, nausea and muscle pain. In some cases, it can also damage the liver. Even then, the injection can only keep the disease at bay for, on average, two months, the trial showed. And only a fifth of fulvestrant patients go six months without their cancer spreading. But the vepdegestrant trial, presented at the American Society for Clinical Oncology conference in Chicago, found that the tablet halted the spread of breast cancer for, on average, five months. Moreover, nearly half of the 300 patients given vepdegestrant went six months without their cancer spreading. The study found that the drug, which also blocks cancer cells from consuming oestrogen, has no major side effects. Experts say it is too soon to say exactly how much longer vepdegestrant patients live than those on fulvestrant, but they expect the difference to be significant. The drug is already being fast-tracked for use in the US and has been sent for approval in the UK. Experts believe it could get the greenlight in the UK because it is so much better than the existing options. 'Fulvestrant is incredibly painful and uncomfortable for patients, the majority of whom are forced to have to come to the clinic for it,' says Professor Komal Jhaveri, an oncologist at the Memorial Sloan Kettering Cancer Centre in New York. 'Oral tablets can be taken at home.' Dr Jane Meisel, a medical oncology professor at Emory University in Georgia, said: 'This drug will be a very exciting option for patients that could transform treatment.' Given it can be taken at home, does not leave patients suffering debilitating side effects, 'it's definitely the first of its kind', she added.
BBC News
an hour ago
- BBC News
West Midlands Combined Authority CEO Laura Shoaf steps down
The chief executive of the West Midlands Combined Authority (WMCA) is stepping down after four years in the Shoaf will remain in the role until 17 June and will continue as chair of Shadow Great British Railways, which was set up last year by the government under its plans to bring the UK's railways back into public Shoaf said she was "sad" to be leaving the organisation she has been with since its inception, but was confident she was leaving it in good WMCA said Ed Cox, deputy chief executive, will step up as interim chief while a recruitment process gets under way for a permanent replacement. "I have lived and worked in the West Midlands for over 20 years, and I am proud that I have been able to make a real difference for our residents," Ms Shoaf said."I will always champion our wonderful region and while I am sad to be leaving the combined authority, I know I am leaving it with people who care passionately about the West Midlands and will continue to see it go from strength to strength." CBE honour West Midlands Mayor Richard Parker said Ms Shoaf had done an "exemplary job for the region" during her time in the 2022, she was honoured with a CBE for services to economic regeneration in the West Midlands."I want to thank Laura for her decades of service to the West Midlands," the mayor said."I especially want to recognise the work she has done in my first year to help me embed and deliver my priorities."I want to wish her every success in the future, especially continuing in her role as Chair of Shadow Great British Railways." This news has been gathered by the Local Democracy Reporting Service Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
